iA Global Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-1,950
Closed -$294K – 429
2025
Q1
$294K Hold
1,950
– – 0.01% 386
2024
Q4
$360K Sell
1,950
-21,080
-92% -$4.06M 0.01% 358
2024
Q3
$4.54M Buy
23,030
+22,610
+5,383% +$4.7M 0.08% 170
2024
Q2
$87K Sell
420
-30
-7% -$6.8K ﹤0.01% 461
2024
Q1
$122K Buy
450
+10
+2% +$2.39K ﹤0.01% 452
2023
Q4
$104K Sell
440
-10
-2% -$1.97K ﹤0.01% 454
2023
Q3
$88K Buy
+450
New +$92.4K ﹤0.01% 458

Other funds holding CRL

iA Global Asset Management's CRL Position: Q2 2025 in Review

iA Global Asset Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 1,950 shares — an estimated $294K sold.

iA Global Asset Management first reported a position in CRL in Q3 2023 and held it in 7 quarters. The position peaked at $4.54M in Q3 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • iA Global Asset Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • iA Global Asset Management sold 1,950 Charles River Laboratories shares in Q2 2025, an estimated $294K.
  • iA Global Asset Management first reported a position in Charles River Laboratories in Q3 2023 and held it in 7 quarters.
  • iA Global Asset Management's Charles River Laboratories position peaked at $4.54M in Q3 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on iA Global Asset Management's 13F filing for Q2 2025, filed 5 Aug 2025.